欧美特黄aaaaa,欧洲成人在线,狠狠综合久久久久综合,亚洲视频一区网站

服務(wù)熱線

15021010459
技術(shù)文章
當(dāng)前位置:主頁 > 技術(shù)文章 > Ariad抗癌藥Iclusig重返市場

Ariad抗癌藥Iclusig重返市場

更新時(shí)間:2014-01-20 點(diǎn)擊次數(shù):1631

    去年Ariad Pharmaceuticals公司業(yè)績由于主打抗癌藥物Iclusig被緊急下架而遭受重創(chuàng)。公司一度陷入困境并將其在美國的員工裁員160人,約占美 國分部總員工數(shù)的40%,以節(jié)省開支。不過現(xiàn)在Ariad Pharmaceuticals公司迎來一絲曙光。公司已經(jīng)著手將Iclusig重新推向市場。此次Ariad將把Iclusig的適用癥范圍縮小,并在 藥物包裝上標(biāo)明可能出現(xiàn)的副作用如心臟病、血液凝塊等。不過由于Iclusig適用范圍變小,公司的收入可能也會大受影響。為解決這一問題公司計(jì)劃申請重 啟此前被FDA下令暫停的關(guān)于Iclusig治療慢性白血病的研究計(jì)劃以達(dá)到亡羊補(bǔ)牢的作用。

    不過Ariad Pharmaceuticals公司的這一系列舉措能否獲得預(yù)期效果還需要等待公司2014年*季度財(cái)報(bào)公布后才能知曉。

詳細(xì)英文報(bào)道:

    Last year, Ariad Pharmaceuticals ($ARIA) watched more than $2.5 billion melt off its market cap when the cancer-fighting Iclusig began a downward spiral that would eventually remove it from the market. But now begins the rebuilding project, as the Cambridge, MA, drugmaker has relaunched its sole product with a lot of ground to make up.

    The drug is now indicated for a smaller group of leukemia patients than before, and it carries a serious boxed warning about the risk of clotting and heart failure that got it pulled from shelves in the fall. But it is for sale, and that puts Ariad in a better place than many predicted at its nadir.

    "We are back on track," CEO Harvey Berger told Bloomberg last month. "We'll enter 2014 largely where we were as we started off the fall in September."

    Of course, that's not entirely the case. Losing more than half of its value forced Ariad to considerably thin its ranks, laying off 40% of its U.S. workforce--or 160 employees--in an effort to save $26 million. Now the company plans to gradually ramp up stateside sales with the help of specialty pharmacy Biologics, Inc., first looking to transition the case-by-case patients who were still using the drug during its marketing hiatus.

    And the company has a long way to go on the R&D side. When the storm over Iclusig began, Ariad was in the process of testing the drug in a broader population, but an FDA-imposed clinical hold led the company to discontinue a Phase III study on patients with newly diagnosed chronic myeloid leukemia and put the brakes on a fleet of Phase II studies designed to expand the drug's market. Berger has said that Ariad is yet to decide just how to move forward with its paused programs.

    Still, the biotech is undeniably sitting prettier than it was just two months ago, and its next big test will come when Q1 sales figures roll in.——(華雅干細(xì)胞整理報(bào)道)

2025 版權(quán)所有 © 重慶市華雅干細(xì)胞技術(shù)有限公司  備案號:渝ICP備14000349號-4 sitemap.xml 管理登陸 技術(shù)支持:化工儀器網(wǎng)

地址:重慶市江北區(qū)金渝大道153號8棟20-14 傳真:023-63419626 郵件:sales@ys-bio.com

重慶市華雅干細(xì)胞技術(shù)有限公司主要經(jīng)營干細(xì)胞研究 干細(xì)胞治療產(chǎn)品 生物試劑 實(shí)驗(yàn)耗材 藥物研發(fā)等產(chǎn)品。

關(guān)注我們

服務(wù)熱線

400-021-2200

掃一掃,關(guān)注我們

日本天码aⅴ片在线电影网站| 亚洲色图17p| 中日韩中文字幕| 欧美久久综合网| 国产无遮挡猛进猛出免费软件| 国产a级特黄的片子视频| 国产美女被爽到高潮免费A片| 高清视频在线观看| 欧产日产国产精品专区| FREE性满足VIDE0SHD| 亚洲综合激情另类专区老铁性| 任天堂全新AV线| 拔萝卜在线视频免费观看| 国产69精品麻豆久久久久| 国产欧美日韩| 中文字幕在线2021一区| 曰本女人一级毛片看一级**| 青梅被从小摸到大H补课1视频| 色播在线永久免费视频网站| 免费a级在线观看播放| 人妻激情偷乱视频一区二区三区| 亚洲精品国产福利| 亚洲AV无码成人精品区狼人影院| 最新精品亚洲成a人在线观看| 内地精品露脸自拍视频香蕉| 久热re在线视频精品免费| 狠狠狠色丁香婷婷综合激情| 御书房双乳晃动干柴烈| 好紧好大快点舒服使劲| 亚洲综合色成在线播放| 91大神免费视频| 性肥胖BWBWBW| 看av的网站| 日本欧美一区二区三区在线| 日本高清免费不卡视频| 伊人久久大香线蕉精品哪里| 台湾佬中文娱乐网| CHINESE熟女老女人HD| 日日摸夜夜添夜夜| 亚洲免费视频一区二区三区| 我被五个黑人p了一夜|